Discounted Cash Flow (DCF) Analysis Unlevered
Octopus Biosafety SA (MLOCT.PA)
0.282 €
-0.00 (0.00%)
All numbers are in Millions, Currency in USD
Operating Data
Year A/P |
Revenue |
---|
Revenue (%) |
EBITDA |
EBITDA (%) |
EBIT |
EBIT (%) |
Depreciation |
Depreciation (%) |
Balance Sheet Data
Year A/P |
Total Cash |
---|
Total Cash (%) |
Account Receivables |
Account Receivables (%) |
Inventories |
Inventories (%) |
Accounts Payable |
Accounts Payable (%) |
Capital Expenditure |
Capital Expenditure (%) |
Weighted Average Cost Of Capital
Share price | $ 0.282 |
---|---|
Beta | 1.495 |
Diluted Shares Outstanding | 2.22 |
Cost of Debt | |
Tax Rate | 0.00 |
After-tax Cost of Debt | 3.40% |
Risk-Free Rate | |
Market Risk Premium | |
Cost of Equity | 11.601 |
Total Debt | 0.15 |
Total Equity | 0.63 |
Total Capital | 0.77 |
Debt Weighting | 19.22 |
Equity Weighting | 80.78 |
Wacc |
Build Up Free Cash
Year A/P |
Revenue |
---|
EBITDA |
EBIT |
Tax Rate |
EBIAT |
Depreciation |
Accounts Receivable |
Inventories |
Accounts Payable |
Capital Expenditure |
UFCF |
WACC |
PV UFCF |
SUM PV UFCF |
Terminal Value
Growth in perpetuity method: | |
---|---|
Long-term growth rate | |
WACC (%) | - |
Free cash flow (t + 1) | - |
Terminal Value | - |
Present Value of Terminal Value | - |
Intrinsic Value
Enterprise Value | - |
---|---|
Net Debt | 0.15 |
Equity Value | - |
Shares Outstanding | 2.22 |
Equity Value Per Share | - |